REFERENCES
- Carson DA, Ribeiro JM: Apoptosis and disease. Lancet 341: 1251–1254, 1993.
- Watanabe-Fukunaga R, Brannan CI, Copeland BG et al.: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314–317, 1992.
- Strasser A, Whittingham S, Vaux DL et al.: Enforced BCL2 expression in B-lymphotd cells prolongs antibody responses and elicites autoimmune disease. Proc Natl Acad Sci USA 88: 8661–8665, 1991.
- Mountz JD, Wu J, Cheng J et al.: Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum V): 1415–1420, 1994.
- Elkon EB: Apoptosis in SLE —too little or too much? Clin Exp Rheumatol 12: 553–559, 1994.
- Yoshino T, Kondo E, Cao L et al: Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 83: 1856–1861, 1994.
- Salmon M, Pilling D, Borthwick NJ et al: The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 24: 892–899, 1994.
- Emlen W, Niebur J, Kadera R: Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 152: 3685–3692, 1994.
- Mysler E, Bini P, Drappa J et ai: The apoptosis-1/Fas protein in human systemic lupus erythematosus. J Clin Invest 93: 1029–1034, 1994.
- Ohsako S, Hara M, Harigai M et al.: Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin Immunol Immunopathol 73: 109–114, 1994.
- Aringer M, Wintersberger W, Steiner CW et al: High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 10: 1423–1430, 1994.
- Ichikawa Y, Arimori K, Yoshida M et al: Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjogren’s syndrome. Clin Exp Rheumatol 13:307–313, 1995.
- Tan EM, Cohen AS, Fries JF et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277, 1982.
- Arnett FC, Edworthy SM, Bloch DA et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315–324, 1988.
- Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. J Am Med Ass 140: 659–662, 1949.
- Nicoletti I, Migliorati G, Pagliacci MC et al: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271–279, 1991.
- Uehara T, Miyawaki T, Olita K et al: Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 80: 452–458, 1992.
- Huang Y-P, Perrin LH, Miescher PA et al: Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol 141: 827–833, 1988.
- Massaia M, Borrione P, Attisano C et al: Dysregulated Fas and bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood 85: 3679–3687, 1995.